Trial Details
COMPLETEDBasic Information
| Clinical ID | c965 |
|---|---|
| Identifier | NCT05061446 |
| Trial Title | Etrasimod Dose-Ranging Versus Placebo as Induction Therapy Study in Adult Japanese Subjects With Moderately to Severely Active Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: Etrasimod|DRUG: Etrasimod|DRUG: Placebo |
Participant Information
| Sponsor | Pfizer |
|---|---|
| City | Toyohashi-shi |
| Country/Region | Japan |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2021-09-10 |
|---|---|
| Primary Completion Date | 2023-10-06 |
| Completion Date | 2023-10-06 |